–
Monopar Therapeutics
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.13
FY22:
−10.5
FY23:
−8.83
FY24:
−16.2
FY25:
−16.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.13
FY22:
−10.5
FY23:
−8.83
FY24:
−16.2
FY25:
−16.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.10
FY22:
−10.5
FY23:
−8.40
FY24:
−15.6
FY25:
−13.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.10
FY22:
−10.5
FY23:
−8.40
FY24:
−15.6
FY25:
−13.7
All amounts in millions USD